Miloš Dendis

Czech Business Angel Association (CBAA) is the national association connecting angel investors in the Czech Republic and representing their interests. Along with our members, we build a vibrant investment climate that follows high professional standards and ethical principles. Our main objective is to nurture and promote active relations between investors and start-ups in the Czech Republic so that they provide a stable foundation for innovation and progress. We realize that the freedom of thought, access to the quality talent pool but also access to the capital are the best prerequisites for creating a thriving business climate. At the same time, we believe that the best investment ecosystems complement each other and grow only when cooperating closely. Within our association, we enable the sharing of experience and business opportunities by building a quality network across angel investors and their groups. We raise awareness of angel investing and represent the interests of fellow angels at the national and international levels.

Czech Business Angel Association (CBAA) is the national association connecting angel investors in the Czech Republic and representing their interests. Along with our members, we build a vibrant investment climate that follows high professional standards and ethical principles. Our main objective is to nurture and promote active relations between investors and start-ups in the Czech Republic so that they provide a stable foundation for innovation and progress. We realize that the freedom of thought, access to the quality talent pool but also access to the capital are the best prerequisites for creating a thriving business climate. At the same time, we believe that the best investment ecosystems complement each other and grow only when cooperating closely. Within our association, we enable the sharing of experience and business opportunities by building a quality network across angel investors and their groups. We raise awareness of angel investing and represent the interests of fellow angels at the national and international levels.

We are a family investment fund that sees value in the development and support of projects for the next generation. Our journey began in a small start-up, and through dedication and successes, we have transformed into an established company with an international business network. We are now using this evolution to put investment capital, courage and know-how into other innovative projects.

The goal of our company is to meet customer needs in the field of routine molecular microbiological, genetic, oncogenetic and prenatal diagnostics based on the Polymerase Chain Reaction (PCR) method. The company is engaged in the development, manufacturing and distribution of high-quality affordable products which are user-friendly and technologically advanced. We offer the solution for all types of diagnostic laboratories that examine clinical samples using molecular-biology methods. We enable each laboratory to start working with these methods or switch from one device platform to another depending on the needs and level of the particular laboratory. GeneProof a.s. is EN ISO 13485:2012 and EN ISO 9001:2009 certified. The subject of the certification is design, development, manufacturing and sales of in vitro diagnostics medical agents. The Company has been audited for CE IVD products by the NB1023 Notified Body according to the Council and European Parliament Directive 98/79/EC on in vitro diagnostic medical agents. Products supplied under the GeneProof brand are characterized by high-quality, which is continually tested by QCMD and INSTAND e. V. External Quality Assessment Panels, user-friendly handling and high professional level of our personnel. We are always ready to provide our expert knowledge and experience not only to the users of GeneProof products. Individual approach to our customers and the high level of customer service are our priorities. The focus of GeneProof on product quality and end-users makes our products an unmatched economical solution for small, medium and large laboratories.